White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study

Neurology

Volumn 75, Issue 2, 2010, Pages 160-167

  Verdelho, A ^a   Madureira, S ^a   Moleiro, C ^b   Ferro, J M ^a   Santos, C O ^a   Erkinjuntti, T ^c   Pantoni, L ^d   Fazekas, F ^e   Visser, M ^f   Waldemar, G ^g   Wallin, A ^h   Hennerici, M ⁱ   Inzitari, D ^d  

^a UNIVERSITY OF LISBON   (Portugal)

^b INSTITUTO UNIVERSITÁRIO DE LISBOA ISCTE IUL   (Portugal)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF GRAZ   (Austria)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Mental Health Services CPH   (Denmark)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GERIATRIC CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL LOBE; WHITE MATTER;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ATROPHY; BRAIN; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DISABILITY EVALUATION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77954692369     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e7ca05     Document Type: Article

References (40)

1. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041.
2. Garde E, Mortensen EL, Krabbe K, et al. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 2000;356:628-634.
3. Kramer JH, Mungas D, Reed BR, et al.
4. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004;63:246-253.
5. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology 2003;22:13-22.
6. Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009;73:120-125.
7. Capizzano AA, Acion L, Bekinschtein T, et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:822-827.
8. Hirono N, Kitagaki H, Kazui H, Hashimoto M, Mori E. Impact of white matter changes on clinical manifestation of Alzheimer's disease: a quantitative study. Stroke 2000; 31:2182-2188.
9. Mungas D, Harvey D, Reed BR, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005;65:565-571.
10. van de Pol LA, Korf ES, van der Flier WM, et al. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol 2007;64:1023-1028.
11. DeCarli C, Mungas D, Harvey D, et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 2004;63:220-227.
12. Ruitenberg A, Skoog I, Ott A, et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001;12:33-39.
13. Tzourio C, Dufouil C, Ducimetiere P, et al. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly: EVA Study Group: epidemiology of vascular aging. Neurology 1999;53:1948-1952.
14. Henon H, Pasquier F, Leys D. Poststroke dementia. Cere-brovasc Dis 2006;22:61-70.
15. Rastas S, Pirttila T, Mattila K, et al. Vascular risk factors and dementia in the general population aged >85 years: prospective population-based study. Neurobiol Aging 2010;31:1-7.
16. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Plet-nikova O, O'Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 2008;64:168-176.
17. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungshol-men project: a 6-year follow-up study. Neurology 2004 12;63:1181-1186.
18. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74.
19. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005;48: 2460-2469.
20. Pantoni L, Basile AM, Pracucci G, et al. Impact of age-related cerebral white matter changes on the transition to disability: the LADIS Study: rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
21. Madureira S, Verdelho A, Ferro JM, et al. Development of a neuropsychological battery for a multinational study: the LADIS. Neuroepidemiology 2006;27:101-116.
22. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol 1987;8:421-426. (Pubitemid 17075726)
23. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
24. Welsh KA, Breitner JCS, Magruder-Habib KM. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:103-110.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
26. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988;24:709-711.
27. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry 1988;23:271-284.
28. van Straaten E, Fazekas F, Rostrup E, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS Study. Stroke 2006;37: 836-840.
29. Scheltens P, Leys D, Barkhof F, et al. Atrophy of the medial temporal lobes on MRI in probable Alzheimer's disease and normal aging: diagnostic value and neuro-psychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-972.
30. Verdelho A, Madureira S, Ferro JM, et al. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly: the LADIS Study. J Neurol Neurosurg Psychiatry 2007;78:1325-1330.
31. Bombois S, Debette S, Bruandet A, et al. Vascular subcor-tical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. Stroke 2008;39:2046-2051.
32. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 2002;99:4703-4707.
33. Tyas SL, Salazar JC, Snowdon DA, et al. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol 2007;165:1231-1238.
34. Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke 2008;39:36-41.
35. Yip AG, Brayne C, Matthews FE, MRC Cognitive Function And Ageing Study. Risk factors for incident dementia in England and Wales: The Medical Research Council Cognitive Function and Ageing Study: a population-based nested case-control study. Age Ageing 2006;35:154-160.
36. Meyer JS, Huang J, Chowdhury MH. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias. J Neurol Sci 2007; 257:97-104.
37. Jagust WJ, Zheng L, Harvey DJ, et al. Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 2008;63:72-80.
38. Peters R, Beckett N. Hypertension, dementia, and antihy-pertensive treatment: implications for the very elderly. Curr Hypertens Rep 2009;11:277-282.
39. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006;2:CD004034. 40.
40. Shah RC, Wilson RS, Bienias JL, Arvanitakis Z, Evans DA, Bennett DA. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology 2006;26: 30-36.